Digital Biology Global Market Report 2025

The digital biology market involves the integration of computational tools, digital technologies, and advanced laboratory systems to model, simulate, and analyze biological processes at molecular, cellular, and organismal levels. By transforming biological information into digital formats, it enables precise understanding, experimentation, and innovation across various life science applications.

The major components of digital biology include software, hardware, and services. Digital biology software refers to computer programs and platforms designed to model, simulate, analyze, and interpret biological systems and processes using computational approaches. The deployment modes include on-premises and cloud, incorporating technologies such as artificial intelligence in biology, bioinformatics tools and software, blockchain for data integrity, cloud computing solutions, and deoxyribonucleic acid data storage technology. The key applications include drug discovery, agriculture, environmental monitoring, personalized medicine, synthetic biology, bioinformatics, and others. These applications are utilized by pharmaceutical and biotechnology companies, research and academic institutes, healthcare providers, contract research organizations, and government and regulatory bodies.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The digital biology market research report is one of a series of new reports from The Business Research Company that provides digital biology market statistics, including digital biology industry global market size, regional shares, competitors with a digital biology market share, detailed digital biology market segments, market trends and opportunities, and any further data you may need to thrive in the digital biology industry. This digital biology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The digital biology market size has grown rapidly in recent years. It will grow from $14.18 billion in 2024 to $15.97 billion in 2025 at a compound annual growth rate (CAGR) of 12.6%. The growth during the historic period is driven by increasing adoption of bioinformatics tools, expansion of genomics and proteomics research, advancements in cloud computing for biological data, rising demand for personalized medicine, and enhanced government funding for life sciences research.

The digital biology market size is expected to see rapid growth in the next few years. It will grow to $25.98 billion in 2029 at a compound annual growth rate (CAGR) of 12.9%. The growth in the forecast period can be connected to integration of ai and machine learning in biology software, expansion of synthetic biology applications, increasing investment in digital therapeutics, growth of in silico drug discovery platforms, and rising demand for automated laboratory solutions. Major trends in the forecast period include use of digital twins for biological systems, collaborative cloud based research platforms, adoption of blockchain for biological data security, predictive modelling for disease progression, and real time simulation of cellular processes.

The surge in healthcare research and development expenditure is expected to contribute to the growth of the digital biology market going forward. Healthcare research and development refers to the systematic efforts to create, test, and enhance medical treatments, devices, and procedures to improve health outcomes and patient care. The increase in healthcare research and development expenditure results from the growing demand for innovative treatments and advanced therapies, as organizations allocate more resources to developing new drugs, medical devices, and personalized medicine solutions that address complex and emerging health challenges. Healthcare research and development spending supports digital biology by funding the creation of advanced computational tools and bioinformatics platforms, which enable faster analysis of biological data and more accurate disease modeling to improve diagnostics and treatments. For instance, in June 2025, the Department for Science, Innovation and Technology, a United Kingdom-based government ministry, announced an investment of $114.38 billion (£86 billion) over four years to support science and technology research and development, including drug development, with annual spending of $29.93 billion (£22.5 billion). Therefore, the surge in healthcare research and development expenditure is supporting the growth of the digital biology market.

Prominent companies in the big data professional services market are prioritizing the creation of data fabric solutions to ensure smooth integration, management, and accessibility of data across hybrid and multi cloud infrastructures, thereby strengthening real time analytics, operational performance, and data driven decision making. For example, in September 2025, Cisco, a US based software enterprise, unveiled Cisco Data Fabric, a platform developed to transform how organizations handle and leverage machine data to advance artificial intelligence projects. Supported by Splunk, this framework aims to minimize expenses and complexity linked with managing vast amounts of machine data. Cisco Data Fabric enhances data operations, improves accessibility for AI utilization, and boosts scalability and efficiency for enterprises working with large scale datasets.

In January 2025, Merck, a Germany-based pharmaceutical and life sciences company, acquired HUB Organoids Holding B.V. for an undisclosed amount. The acquisition expands Merck's next-generation biology portfolio, enhancing its expertise in advanced organoid platforms and next-generation biology tools to accelerate innovation in drug discovery and personalized medicine. HUB Organoids Holding B.V. is a Netherlands-based digital biology company that specializes in developing advanced organoid platforms and next-generation in vitro models.

Major players operating in the digital biology market are Thermo Fisher Scientific, Illumina Inc., Qiagen N.V., F. Hoffmann-La Roche Ltd., Perkin Elmer, Agilent Technologies Inc., BGI Genomics Co. Ltd., DNAnexus Inc., Seven Bridges Genomics Inc., GenBio Inc., Evogene Ltd., Cradle B.V., Ginkgo Biosecurity, Evolutionary Scale Inc., Naturannova S.A., Nexco Analytics Inc., Latent Labs Inc., BioLizard NV, Lamin Labs Inc., LatchBio Inc., Standard BioTools Inc., Recursion Pharmaceuticals Inc., Insilico Medicine Inc., Deep Genomics Inc., Valo Health Inc., LabGenius Ltd., Arzeda Corp., e-Therapeutics plc, Bio-Map, A-Alpha Bio Inc., Eikon Therapeutics Inc., Proscia Inc., Lifebit Biotech Ltd., Genestack Ltd., Seqera Labs SL, Sciepot, Pluto Biosciences Inc., SciNote LLC, Qlucore AB, 10x Genomics Inc., Bruker Corporation, Bio-Techne Corporation, Resolve Biosciences GmbH, RareCyte Inc., Oxford Nanopore Technologies plc, PacBio, Ultima Genomics Inc., Element Biosciences Inc., Benchling Inc., and Synthace Ltd.

North America was the largest region in the digital biology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the Digital Biology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the digital biology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The digital biology market consists of revenues earned by entities by providing services such as bioinformatics services, genomic sequencing and analysis, and molecular diagnostics support. The market value includes the value of related goods sold by the service provider or included within the service offering. The digital biology market also includes of sales of bioinformatics platforms, biological database subscriptions, synthetic biology design tools, laboratory automation instruments, and high-performance computing systems for biological research. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Digital Biology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on digital biology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for digital biology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The digital biology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Component: Software, Hardware, Services
• 2) By Deployment Mode: On Premises, Cloud
• 3) By Technology: Artificial Intelligence In Biology, Bioinformatics Tools And Software, Blockchain For Data Integrity, Cloud Computing Solutions, Deoxyribonucleic Acid Data Storage Technology
• 4) By Application: Drug Discovery, Agriculture, Environmental Monitoring, Personalized Medicine, Synthetic Biology, Bioinformatics, Other Applications
• 5) By End User: Pharmaceutical and Biotechnology Companies, Research and Academic Institutes, Healthcare Providers, Contract Research Organizations, Government and Regulatory Bodies
• Subsegments:
• 1) By Software: Genomic Data Analysis, Proteomics Analysis, Metabolomics Analysis, Transcriptomics Analysis, Clinical Bioinformatics, Data Visualization Tools, Laboratory Information Management Systems
• 2) By Hardware: Sequencing Instruments, Mass Spectrometry Systems, Microscopy Instruments, Chromatography Equipment, Cell Culture Instruments, Laboratory Automation Equipment
• 3) By Services: Bioinformatics Consulting, Data Management Services, Genetic Testing Services, Clinical Trial Support Services, Custom Assay Development, Laboratory Management Services, Training And Support Services
• Companies Mentioned: Thermo Fisher Scientific, Illumina Inc., Qiagen N.V., F. Hoffmann-La Roche Ltd., Perkin Elmer, Agilent Technologies Inc., BGI Genomics Co. Ltd., DNAnexus Inc., Seven Bridges Genomics Inc., GenBio Inc., Evogene Ltd., Cradle B.V., Ginkgo Biosecurity, Evolutionary Scale Inc., Naturannova S.A., Nexco Analytics Inc., Latent Labs Inc., BioLizard NV, Lamin Labs Inc., LatchBio Inc., Standard BioTools Inc., Recursion Pharmaceuticals Inc., Insilico Medicine Inc., Deep Genomics Inc., Valo Health Inc., LabGenius Ltd., Arzeda Corp., e-Therapeutics plc, Bio-Map, A-Alpha Bio Inc., Eikon Therapeutics Inc., Proscia Inc., Lifebit Biotech Ltd., Genestack Ltd., Seqera Labs SL, Sciepot, Pluto Biosciences Inc., SciNote LLC, Qlucore AB, 10x Genomics Inc., Bruker Corporation, Bio-Techne Corporation, Resolve Biosciences GmbH, RareCyte Inc., Oxford Nanopore Technologies plc, PacBio, Ultima Genomics Inc., Element Biosciences Inc., Benchling Inc., and Synthace Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.